By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Charleston Laboratories, Inc. 

65 Gasden Street
Suite 201
Charleston  South Carolina  29401  U.S.A.
Phone: 843-577-2626 Fax: 843-628-1061



Start Up

Company News
Charleston Laboratories Announces Senior Global Regulatory Hire 2/15/2017 9:55:12 AM
Charleston Laboratories And Daiichi Sankyo Receive Complete Response Letter From FDA For New Drug Application For CL-108 (Hydrocodone, Acetaminophen, Promethazine) Tablets For Oral Use 2/3/2017 11:23:16 AM
Charleston Laboratories Announces Formation Of U.S. Commercial Subsidiary 1/26/2017 11:49:44 AM
Charleston Laboratories Release: Company Expands Senior Management Team With Two Key Appointments In Core Business Areas Of Medical & Commercialization 1/24/2017 9:50:34 AM
Charleston Laboratories And Daiichi Sankyo Announce FDA Acceptance Of New Drug Application (NDA) For CL-108 6/13/2016 10:25:28 AM
Charleston Laboratories Announces Presentations At The Annual Scientific Meeting Of The American Pain Society 5/11/2016 8:08:00 AM
Charleston Laboratories to Create New Jobs in Florida Expansion 1/21/2016 6:11:29 AM
Charleston Laboratories, Inc. And Daiichi Sankyo Announce Phase 3 Study Of CL-108 Met Primary Endpoints 10/29/2015 6:22:52 AM
Charleston Laboratories, Inc. Announces Completion Of A Second Phase 3 Clinical Trial On Its Lead Product, CL-108, And The Appointment Of Dr. Raymond Dionne To Its Scientific Advisory Board 8/20/2015 6:15:20 AM
Charleston Laboratories, Inc. Initiates Patient Enrollment In A Phase 1 Study Of Charleston's Second Product, CL-H1T 8/3/2015 6:27:21 AM